Osteopore Ltd. (AU:OSX) has recently provided an update on their latest advancements. The company has reported significant progress in their A$18.7m project in collaboration with NDCS and A*STAR. They have successfully developed a 3D-printed technology for dental implants that aims to improve bone regeneration.
The innovative technology combines biological additives with polymer compounds, resulting in promising non-cytotoxic responses and enhanced osteogenic differentiation. This breakthrough has positioned Osteopore in the competitive global dental bone graft and membrane substitute market. The company has plans to advance into in vivo studies to further validate the effectiveness of their product.
For investors interested in learning more about AU:OSX stock, TipRanks’ Stock Analysis page offers valuable insights and analysis.